Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-18-000005)

Filing Details

Accession Number:: 0000711377-18-000005
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-02-22 20:51:36
Reporting Period:: 2018-02-20

Accepted Time:: 2018-02-22 20:51:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1168789	L James Herbert	Neogen Corp 620 Lesher Place Lansing MI 48912	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-02-20	6,665	$40.46	1,157,591	No	4	M	Direct
Common Stock	Disposition	2018-02-20	6,665	$59.32	1,150,926	No	4	S	Direct
Common Stock	Acquisiton	2018-02-21	18,669	$40.46	1,169,595	No	4	M	Direct
Common Stock	Disposition	2018-02-21	18,669	$59.32	1,150,926	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock (Right to Buy)	Disposition	2018-02-20	6,665	$0.00	6,665	$40.46
Common Stock	Common Stock (Right to Buy)	Disposition	2018-02-21	18,669	$0.00	18,669	$40.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
370,672		2021-10-29	No	4	M	Direct
352,003		2021-10-29	No	4	M	Direct

Footnotes

Options were granted 9/29/2016, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant